세포 용해 시장 규모, 점유율, 성장 분석 : 제품 유형별, 세포 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Cell Lysis Market size was valued at USD 3.57 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 6.67 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The cell lysis market is experiencing robust growth, fueled by the escalating demand for cell lysis techniques across diverse research fields, including genomics, proteomics, and cell-based assays. Essential for extracting key intracellular components and biomolecules-such as DNA, RNA, proteins, and organelles-cell lysis plays a vital role in analysis and experimentation. The surge in drug discovery efforts, the move towards personalized medicine, and advancements in biotechnology significantly boost demand for efficient, high-quality cell lysis methods. Additionally, the rising incidence of chronic diseases and the growing need for precise diagnostic tools further propel the market's expansion. Innovations and automation in cell lysis technologies position the market favorably for sustained growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Lysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Lysis Market Segments Analysis

Global Cell Lysis Market is segmented by product, cell type, application, end user, research laboratories and institutes, biopharmaceutical and biotechnology companies, other end user and region. Based on product, the market is segmented into consumables and instruments. Based on cell type, the market is segmented into mammalian cells, microbial cells, bacterial cells and other cells. Based on application, the market is segmented into protein purification and isolation, cell organelle isolation, nucleic acid isolation and purification and other application. Based on end user, the market is segmented into Research Laboratories and Institutes, biopharmaceutical and biotechnology companies, other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Lysis Market

A significant factor propelling the global cell lysis market is the surging demand for cell-based research and development across diverse sectors such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis plays a crucial role in isolating cellular components for in-depth analysis and experimentation, which is becoming increasingly vital due to the heightened emphasis on personalized medicine, drug discovery, and genomics research. Furthermore, ongoing advancements in cell lysis technologies, including bead-based techniques and high-throughput systems, are enhancing market expansion by providing improved efficiency, scalability, and reproducibility in research processes. These trends collectively contribute to a thriving environment for cell lysis solutions.

Restraints in the Cell Lysis Market

The global cell lysis market faces a significant challenge due to the high expenses linked to cell lysis products and equipment. The various techniques involved often necessitate the use of specialized reagents, consumables, and instruments, which can be prohibitively costly. This financial burden can be particularly daunting for researchers and laboratories operating on limited budgets, especially in less developed regions. Additionally, the requirement for skilled personnel to execute cell lysis procedures accurately further escalates costs. Such factors can restrict the adoption of cell lysis technologies and consequently impede market growth, especially in resource-limited environments.

Market Trends of the Cell Lysis Market

The cell lysis market is experiencing a notable trend toward the adoption of automated and high-throughput systems. Researchers increasingly require efficient and reliable methods for disrupting cell membranes to extract intracellular components, driven by the complexities of cellular biology. Automated systems present significant advantages, including precise control, reproducibility, and scalability, which streamline cell lysis processes. This automation not only reduces manual labor but also enhances workflow integration across diverse applications such as genomics, proteomics, drug discovery, and diagnostic research. As laboratories aim for improved productivity and consistent, standardized outcomes, the demand for these advanced solutions is anticipated to rise steadily.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Lysis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Kits And Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Disposables
  • Others
• Instruments
  • Sonicators
  • Homogenizers
  • French Press
  • Microfluidizer
  • Bead Mill
  • Other Instruments

Global Cell Lysis Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
• Microbial Cells
• Bacterial Cells
• Other Cells

Global Cell Lysis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Protein Purification And Isolation
• Cell Organelle Isolation
• Nucleic Acid Isolation And Purification
• Other Application

Global Cell Lysis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Research Laboratories And Institutes
• Biopharmaceutical And Biotechnology
• Other End User

Global Cell Lysis Market Size & CAGR (2026-2033)

• North America (Product, Cell Type, Application, End User)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End User,)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covaris, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parr Instrument Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claremont BioSolutions, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qsonica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations